Investor Relations

PluroGen is a privately held corporation with an experienced international corporate leadership and an advisory board that includes key thought leaders, researchers and practitioners in burn and wound care.

We provide technically advanced wound and skin care products and are well positioned to meaningfully advance patient care.  PluroGen Therapeutics has a portfolio of 3 novel, patented and superior technology platforms that provide products already in the market and long-term product pipeline opportunities.

  • Advanced Surfactant-based PluroGel® Biomaterial Technology Platform
  • Nano Metal Technology Platform
  • Polysaccharide Natural Gel Technology Platform

If you are interested in learning more about PluroGen, or for financial or investment inquiries, please contact: or Tel:  +1 (610) 539-3670

Investor Updates